Overview

Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury

Status:
RECRUITING

Trial end date:
2028-05-15

Target enrollment:

Participant gender:

Summary

This trial is to evaluate the efficacy and safety of Amimestrocel (human umbilical cord mesenchymal stromal cells) in the treatment of AKI patients.

Phase:

PHASE2

Details

Lead Sponsor:

Chinese PLA General Hospital